Makary, Prasad Plan New Pilot Program For Swifter Drug Approvals

By Luke Zarzecki / June 10, 2025 at 6:46 PM

FDA Commissioner Marty Makary and biologics center director Vinay Prasad laid out their priorities for the agency in a Journal of the American Medical Association article Tuesday (June 10), saying they will establish a new pilot program to speed up drug approvals, aim to lower drug costs and use artificial intelligence for drug investigations and postmarket surveillance.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.